MsrB1 Promotes Proliferation and Invasion of Colorectal Cancer Cells Via GSK-3β/β-catenin Signaling Axis

Overview

Journal Cell Transplant

Specialties Cell Biology
General Surgery

Date 2021 Nov 1

PMID 34719306

Citations 5

Authors

Xiao-Yu Chen

Sheng-Yong Yang

Xiao-Jie Ruan

Hong-Yue Ding

Ning-Xi Wang

Fang Liu

Jia-Chu Li

Yi Li

Affiliations

Soon will be listed here.

Abstract

Methionine sulfoxide reductase B1 (MsrB1) can catalyze both free and protein-bound R-methionine sulfoxides (R-MetO) to methionine (Met). It has been reported that MsrB1 plays an important role in the development of HCC and human bone osteosarcoma. However, little is known about the functions of MsrB1 in human colorectal cancer (CRC). Herein, we detected MsrB1 expression level in CRC tissue and cell lines, and investigated the effect of MsrB1 knockdown on CRC phenotypes and possible mechanisms involved in. The results showed that MsrB1 was highly expressed in both CRC tissues and cell lines, and that cell proliferation, migration and invasion were significantly inhibited, but apoptosis was increased after MsrB1 knockdown in colorectal cancer HCT116 and RKO cell lines, compared to control siRNA group. In addition, E-cadherin protein level was increased, vimentin and Snail protein were greatly decreased after knockdown of MsrB1 in cells. Furthermore, pGSK-3β (Ser9) and β-catenin protein levels were reduced, the promoter activity of TCF/LEF construction was inhibited after MsrB1 knockdown in cells, suggesting that GSK-3β/β-catenin signaling axis was involved in the tumorigenesis of CRC. In conclusion, the oncogenic role and related mechanisms of MsrB1 in CRC discovered in our work determined the potential role of MsrB1 as a biomarker and may provide a new target for clinical therapy of CRC.

Citing Articles

Development and Optimization of a Redox Enzyme-Based Fluorescence Biosensor for the Identification of MsrB1 Inhibitors.

Shim H, Lee H, Cho H, Jo Y, Tarrago L, Kim H Antioxidants (Basel). 2024; 13(11).

PMID: 39594490 PMC: 11591284. DOI: 10.3390/antiox13111348.

An integrative pan-cancer bioinformatics analysis of MSRB1 and its association with tumor immune microenvironment, prognosis, and immunotherapy.

Jiang S, Yang S, Gao Z, Yin C, Zhang M, Wu Q Heliyon. 2024; 10(4):e26090.

PMID: 38404783 PMC: 10884410. DOI: 10.1016/j.heliyon.2024.e26090.

Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor Cancers.

Shimada B, Swanson S, Toh P, Seale L Biomolecules. 2022; 12(11).

PMID: 36358931 PMC: 9687593. DOI: 10.3390/biom12111581.

RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.

Li Y, Wang N, Yin C, Jiang S, Li J, Yang S Int J Mol Sci. 2022; 23(17).

PMID: 36077054 PMC: 9456332. DOI: 10.3390/ijms23179656.

Long non-coding RNA tumor protein 73 antisense RNA 1 influences an interaction between lysine demethylase 5A and promoter of tumor protein 73 to enhance the malignancy of colorectal cancer.

Huang Z, Wang H, Yang M Hum Cell. 2022; 35(5):1512-1520.

PMID: 35896939 DOI: 10.1007/s13577-022-00740-2.

References

Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J . The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000; 2(2):84-9. DOI: 10.1038/35000034. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Gladyshev V . Selenium and Methionine Sulfoxide Reduction. Free Radic Biol Med. 2015; 75 Suppl 1:S8-9. DOI: 10.1016/j.freeradbiomed.2014.10.848. View

Li Y, Zhang W, Li P, Huang K . Effect of streptozocin-induced diabetes mellitus on expression of methionine sulfoxide reductases and accumulation of their substrates in mouse lenses. Exp Eye Res. 2011; 92(5):401-7. DOI: 10.1016/j.exer.2011.02.014. View

Ding H, Yang W, Zhang L, Li L, Xie F, Li H . 8-Chloro-Adenosine Inhibits Proliferation of MDA-MB-231 and SK-BR-3 Breast Cancer Cells by Regulating ADAR1/p53 Signaling Pathway. Cell Transplant. 2020; 29:963689720958656. PMC: 7784596. DOI: 10.1177/0963689720958656. View

Radak Z, Zhao Z, Goto S, Koltai E . Age-associated neurodegeneration and oxidative damage to lipids, proteins and DNA. Mol Aspects Med. 2011; 32(4-6):305-15. DOI: 10.1016/j.mam.2011.10.010. View

Dobrovolska O, Rychkov G, Shumilina E, Nerinovski K, Schmidt A, Shabalin K . Structural insights into interaction between mammalian methionine sulfoxide reductase B1 and thioredoxin. J Biomed Biotechnol. 2012; 2012:586539. PMC: 3312296. DOI: 10.1155/2012/586539. View

Pescosolido N, Barbato A, Giannotti R, Komaiha C, Lenarduzzi F . Age-related changes in the kinetics of human lenses: prevention of the cataract. Int J Ophthalmol. 2016; 9(10):1506-1517. PMC: 5075670. DOI: 10.18240/ijo.2016.10.23. View

Yang S, Xu H, Yu S, Cao H, Fan J, Ge C . Foxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblasts. J Biol Chem. 2011; 286(21):19149-58. PMC: 3099728. DOI: 10.1074/jbc.M110.197905. View

10.

Drazic A, Winter J . The physiological role of reversible methionine oxidation. Biochim Biophys Acta. 2014; 1844(8):1367-82. DOI: 10.1016/j.bbapap.2014.01.001. View

11.

Lourenco Dos Santos S, Petropoulos I, Friguet B . The Oxidized Protein Repair Enzymes Methionine Sulfoxide Reductases and Their Roles in Protecting against Oxidative Stress, in Ageing and in Regulating Protein Function. Antioxidants (Basel). 2018; 7(12). PMC: 6316033. DOI: 10.3390/antiox7120191. View

12.

Kim H, Gladyshev V . Methionine sulfoxide reductases: selenoprotein forms and roles in antioxidant protein repair in mammals. Biochem J. 2007; 407(3):321-9. DOI: 10.1042/BJ20070929. View

13.

Reiterer M, Schmidt-Kastner R, Milton S . Methionine sulfoxide reductase (Msr) dysfunction in human brain disease. Free Radic Res. 2019; 53(11-12):1144-1154. DOI: 10.1080/10715762.2019.1662899. View

14.

. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012; 487(7407):330-7. PMC: 3401966. DOI: 10.1038/nature11252. View

15.

Prossomariti A, Piazzi G, Alquati C, Ricciardiello L . Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?. Cell Mol Gastroenterol Hepatol. 2020; 10(3):491-506. PMC: 7369353. DOI: 10.1016/j.jcmgh.2020.04.007. View

16.

Szende B, Tyihak E . Effect of formaldehyde on cell proliferation and death. Cell Biol Int. 2010; 34(12):1273-82. DOI: 10.1042/CBI20100532. View

17.

He Q, Li H, Meng F, Sun X, Feng X, Chen J . Methionine Sulfoxide Reductase B1 Regulates Hepatocellular Carcinoma Cell Proliferation and Invasion via the Mitogen-Activated Protein Kinase Pathway and Epithelial-Mesenchymal Transition. Oxid Med Cell Longev. 2018; 2018:5287971. PMC: 5971335. DOI: 10.1155/2018/5287971. View

18.

Li H, He Q, Meng F, Feng X, Chen J, Li L . Methionine sulfoxide reductase B1 regulates proliferation and invasion by affecting mitogen-activated protein kinase pathway and epithelial-mesenchymal transition in u2os cells. Biochem Biophys Res Commun. 2018; 496(3):806-813. DOI: 10.1016/j.bbrc.2018.01.151. View

19.

Kim G, Weiss S, Levine R . Methionine oxidation and reduction in proteins. Biochim Biophys Acta. 2013; 1840(2):901-5. PMC: 3766491. DOI: 10.1016/j.bbagen.2013.04.038. View

20.

Yang S, Jia X, Feng L, Li S, An G, Ni J . Inhibition of topoisomerase II by 8-chloro-adenosine triphosphate induces DNA double-stranded breaks in 8-chloro-adenosine-exposed human myelocytic leukemia K562 cells. Biochem Pharmacol. 2008; 77(3):433-43. DOI: 10.1016/j.bcp.2008.10.022. View